
Tricida TCDA
Quartalsbericht 2022-Q3
hinzugefügt 16.05.2026
Tricida P/B 2011-2026 | TCDA
P/B Jährlich Tricida
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.87 K | 2.35 | 5.72 | 2.63 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.87 K | 2.35 | 471 |
P/B anderer Aktien in der Arzneimittelhersteller
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Endo International plc
ENDP
|
0.0133 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
-0.0724 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
3.46 | $ 5.61 | -1.06 % | $ 83.3 M | ||
|
HEXO Corp.
HEXO
|
0.88 | - | 2.45 % | $ 38.1 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
0.687 | - | -0.1 % | $ 2.03 B | ||
|
AcelRx Pharmaceuticals
ACRX
|
2.78 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
0.703 | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-27.6 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
-18.8 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
-0.0793 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
2.2 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
0.644 | $ 2.67 | 2.69 % | $ 1.02 B | ||
|
Athenex
ATNX
|
-0.473 | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
37.1 | $ 41.94 | 9.22 % | $ 1.54 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
9.71 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
3.01 | - | - | $ 11.5 B | ||
|
Eagle Pharmaceuticals
EGRX
|
1.46 | - | -39.89 % | $ 27.7 M | ||
|
Pacira BioSciences
PCRX
|
1.51 | $ 22.64 | -0.79 % | $ 1.05 B | ||
|
Organogenesis Holdings
ORGO
|
0.777 | $ 2.34 | -2.5 % | $ 297 M | ||
|
Canopy Growth Corporation
CGC
|
0.419 | $ 0.94 | -1.49 % | $ 280 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
0.599 | $ 1.15 | 4.55 % | $ 1.94 M | ||
|
Aurora Cannabis
ACB
|
0.368 | $ 2.92 | -2.67 % | $ 160 M | ||
|
Solid Biosciences
SLDB
|
3.46 | $ 7.31 | 3.39 % | $ 640 M | ||
|
Jupiter Wellness
JUPW
|
-1.09 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
-0.0916 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
0.492 | $ 0.99 | -2.26 % | $ 94.3 M | ||
|
Tilray
TLRY
|
0.358 | $ 4.75 | -2.66 % | $ 2.94 B | ||
|
Veru
VERU
|
4.63 | $ 2.99 | -4.47 % | $ 43.8 M | ||
|
Evolus
EOLS
|
-11.7 | $ 6.74 | 1.66 % | $ 435 M | ||
|
Sundial Growers
SNDL
|
0.000669 | $ 1.44 | 0.7 % | $ 3.37 M | ||
|
Emergent BioSolutions
EBS
|
0.865 | $ 8.14 | 5.03 % | $ 435 M | ||
|
Neoleukin Therapeutics
NLTX
|
0.00923 | - | - | $ 193 M | ||
|
cbdMD
YCBD
|
0.495 | $ 0.69 | 0.47 % | $ 2.78 M | ||
|
Assertio Holdings
ASRT
|
0.802 | $ 23.5 | - | $ 150 M | ||
|
ProPhase Labs
PRPH
|
2.05 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
-1.56 | - | - | $ 1.42 B | ||
|
Bausch Health Companies
BHC
|
5.38 | $ 4.76 | -3.94 % | $ 1.77 B | ||
|
PetIQ
PETQ
|
0.456 | - | 1.64 % | $ 400 M | ||
|
Relmada Therapeutics
RLMD
|
2.85 | $ 6.6 | 0.76 % | $ 261 M | ||
|
Recro Pharma
REPH
|
2.27 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
-0.148 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
0.769 | $ 3.8 | -7.09 % | $ 190 M | ||
|
PLx Pharma
PLXP
|
2.31 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
0.898 | $ 15.73 | -1.93 % | $ 18.3 B | ||
|
Zomedica Corp.
ZOM
|
0.572 | - | -0.21 % | $ 98 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
0.406 | - | - | $ 55.5 M | ||
|
Rockwell Medical
RMTI
|
0.914 | $ 0.65 | -3.93 % | $ 23.4 M | ||
|
China Pharma Holdings
CPHI
|
0.121 | $ 0.84 | 8.65 % | $ 3.6 M | ||
|
TherapeuticsMD
TXMD
|
0.857 | $ 2.27 | -0.87 % | $ 26.3 M |